ETFs Canopy Growth Corporation

WEED

CA1380357048

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 16:00:00 2024-12-13 EST			5-day change	1st Jan Change
4.420 ^CAD	-1.78%		-13.67%	-34.62%

12-09	Canopy Growth Completes Acquisition of Acreage Holdings	MT
12-09	Canopy Growth Brief: Canopy Growth and Acreage Confirming Canopy USA's Completed Acquisition of Acreage	MT

ETFs positioned on Canopy Growth Corporation

Name	Weight	AuM	1st Jan change	Investor Rating
AMPLIFY ETF TR SEYMOUR CANNABIS - USD	3.96%	24 M€	-31.91%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	0.05%	20 M€	+16.38%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - EUR	0.01%	274 M€	+15.64%	-
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - B - USD	0.01%	453 M€	-.--%
CSIF (IE) MSCI WORLD ESG LEADERS BLUE UCITS ETF - BH - CHF	0.01%	216 M€	+14.54%	-

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

Employees

1,029

Sector

Pharmaceuticals

Calendar

2025-02-05 - Q3 2025 Earnings Release (Projected)

More about the company